The Medicines Company Human Resources Contracts & Agreements

35 Contracts & Agreements

Browse by Subcategory

Bonus & Incentive Agreements (16 contracts)
Compensation Agreements (4)
Consulting Agreements (6)
Employment Agreements (4)
Separation Agreements (1)
Severance Agreements (4)

Recent Contracts

Separation Agreement, dated March 15, 2019, between Christopher Cox and the registrant (Filed With SEC on April 26, 2019)
Severance Agreement, dated December 10, 2018, by and between Mark Timney and The Medicines Company (Filed With SEC on December 11, 2018)
Employment Agreement, dated December 10, 2018, by and between Mark Timney and The Medicines Company (Filed With SEC on December 11, 2018)
Form of performance stock option agreement under 2013 Stock Incentive Plan (Filed With SEC on August 2, 2018)
Amendment, dated November 14, 2017, of the Amended and Restated Employment Agreement between The Medicines Company and Clive Meanwell, dated May 26, 2016 (Filed With SEC on March 1, 2018)
AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on June 1, 2016)
AMENDMENT NO. 3 TO THE MEDICINES COMPANY 2013 STOCK INCENTIVE PLAN (Filed With SEC on June 1, 2016)
AMENDMENT NO. 2 TO THE MEDICINES COMPANY 2013 STOCK INCENTIVE PLAN (Filed With SEC on June 2, 2015)
Type of FeeAmount of CompensationAnnual retainer for board members$55,000Additional annual retainer for lead director$10,000Compensation for each board meeting attended in excess... (Filed With SEC on May 5, 2015)
THIRD AMENDMENT TO THE CONSULTING AGREEMENT (Filed With SEC on March 2, 2015)
SECOND AMENDMENT TO THE CONSULTING AGREEMENT (Filed With SEC on March 2, 2015)
AMENDMENT NO. 1 TO THE MEDICINES COMPANY 2013 STOCK INCENTIVE PLAN (Filed With SEC on August 4, 2014)
THE MEDICINES COMPANY Restricted Stock Agreement Granted Under 2013 Stock Incentive Plan (Filed With SEC on August 9, 2013)
THE MEDICINES COMPANY Restricted Stock Agreement Granted Under 2013 Stock Incentive Plan (Filed With SEC on August 9, 2013)
THE MEDICINES COMPANY Non-statutory Stock Option Agreement Under 2013 Stock Incentive Plan (Filed With SEC on August 9, 2013)
THE MEDICINES COMPANY Non-statutory Stock Option Agreement Granted Under 2013 Stock Incentive Plan (Filed With SEC on August 9, 2013)
THE MEDICINES COMPANY 2013 STOCK INCENTIVE PLAN (Filed With SEC on August 9, 2013)
AMENDMENT TO THE CONSULTING AGREEMENT (Filed With SEC on March 1, 2013)
Type of FeeAmount of CompensationAnnual retainer for board members$55,000Additional annual retainer for lead director$10,000Attendance for each board meeting attended in... (Filed With SEC on March 1, 2013)
Exhibit 10.2 CONSULTING AGREEMENT (Filed With SEC on November 9, 2012)
EX-10.42: SEVERANCE AGREEMENT (Filed With SEC on March 2, 2009)
EX-10.25: FORM OF AMENDED AND RESTATED MANAGEMENT SEVERANCE AGREEMENT (Filed With SEC on March 2, 2009)
EX-10.24: FORM OF AMENDED AND RESTATED MANAGEMENT SEVERANCE AGREEMENT (Filed With SEC on March 2, 2009)
Summary of Annual Cash Bonus Plan (Filed With SEC on August 11, 2008)
CONSULTING AGREEMENT (Filed With SEC on May 9, 2007)
Summary of The Medicines Company Board of Directors Compensation (Filed With SEC on May 9, 2007)
THE MEDICINES COMPANY 2004 STOCK INCENTIVE PLAN(1) (Filed With SEC on August 8, 2006)
THE MEDICINESCOMPANY Restricted Stock Agreement Granted Under 2004 Stock Incentive Plan (Filed With SEC on May 10, 2006)
Summary ofThe Medicines Company Board of Director Compensation (Filed With SEC on March 14, 2005)
CONSULTING AGREEMENT (Filed With SEC on March 14, 2005)
THE MEDICINES COMPANY Nonstatutory Stock Option Agreement Under 2004 Stock Incentive Plan (Filed With SEC on March 14, 2005)
FIRST AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on November 5, 2004)
THE MEDICINES COMPANY Nonstatutory StockOption Agreement Under 1998 Stock Incentive Plan (Filed With SEC on August 6, 2004)
THE MEDICINES COMPANY Nonstatutory StockOption Agreement Under 2004 Stock Incentive Plan (Filed With SEC on August 6, 2004)
THE MEDICINES COMPANY 2004 STOCK INCENTIVE PLAN (Filed With SEC on August 6, 2004)